Back to search results

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Abroad (travel likely)Recruiting

Conditions

Age-Related Macular Degeneration · Age-related Macular Degeneration (ARMD) · Intermediate AMD · Geographic Atrophy Secondary to Age-related Macular Degeneration

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Retina Consultants PC, Manchester, Connecticut, United States

    Contact: Study coordinator (Chris Research Coordinator) · cdwy@retinact.com · 860-646-7704 x113
    Contact: Principal Investigator (Noam Rudnick, MD)

  • University Retina & Macula Associates, Lemont, Illinois, United States

    Contact: Study coordinator (Clinical Research Manager) · maggieb@uretina.com · 708-765-4110

  • Sierra Eye Associates, Reno, Nevada, United States

    Contact: Study coordinator (Mandi Research Coordinator) · mseverson@sierraeyeassociates.com · 775-329-0286
    Contact: Principal Investigator (Arshad Khanani)

  • Texas Retina Associates, Fort Worth, Texas, United States

    Contact: Study coordinator (Lori Research Coordinator) · lmullen@texasretina.com · 817-334-0882 x411
    Contact: Principal Investigator (Patrick Williams, MD)

  • Tyler Retina Research Insitute, Tyler, Texas, United States

    Contact: Study coordinator (Melissa Long Research Coordinator) · mlong@tylerretina.com · 903-597-4644
    Contact: Principal Investigator (Samuel Minaker, MD)

  • Sydney Eye Hospital, Sydney, New South Wales, Australia

  • Hobart Eye Surgeons, Hobart, Tasmania, Australia

  • Adelaide Eye & Retina Centre, Adelaide, Victoria, Australia

  • Cerulea, East Melbourne, Victoria, Australia

  • Auckland Eye Limited, Remuera, Auckland, New Zealand

    Contact: Study coordinator (Alice Research Coordinator) · Alice@aucklandeye.co.nz · 64 09 529 2480
    Contact: Principal Investigator (Riyaz Bhikoo)

  • Southern Eye Specialist, Christchurch, New Zealand

    Contact: Study coordinator (Marie Research Coordinator) · marie@southerneye.co.nz · 64 03 355 6397
    Contact: Principal Investigator (James Borthwick)

  • Queens University Belfast / Belfast City Hospital, Belfast, United Kingdom

    Contact: Study coordinator (Therese Research Coordinator) · t.kearney@qub.ac.uk · +44 02895 040342
    Contact: Principal Investigator (Tunde Peto)

  • King's College Hospital, London, United Kingdom

    Contact: Study coordinator (Nikki Research Coordinator) · noimottimson@nhs.net · +44 203 299 7791
    Contact: Principal Investigator (Timothy Jackson, PhD, FRCOphth)

  • London North West University Healthcare, Middlesex, United Kingdom

    Contact: Study coordinator (Sandali Research Coordinator) · snammuniarachchge@nhs.net · +44 (0) 208 453 2077
    Contact: Principal Investigator (Christiana Dinah, BSc, MB BS, MRes, FRCOphth)

  • Sunderland Eye Infirmary, Sunderland, United Kingdom

    Contact: Study coordinator (SEI Research Nurses Research Coordinator) · stsft.seiresearchnurses@nhs.net · 0191 5699074
    Contact: Principal Investigator (Ajay Kotagiri)
Study leads

  • Meredith Mundy

    Study Director

    i-Lumen Scientific, Inc.

View source on ClinicalTrials.gov(opens in a new tab)